CIK 0001701541 · Non-accelerated filer<br>Smaller reporting company
Black Diamond Therapeutics, Inc.
Sign in to watch- Ticker
- BDTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 814254660
- Phone
- 617-417-5868
- Business address
- 245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- Aset Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-15 | Behbahani Ali Director | Grant or award | +3,299 | $3.60 | $12K | 44,069 |
| 2023-07-05 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +935,850 | $5.00 | $4.7M | 3,213,828 |
| 2023-07-05 | Behbahani Ali Director | Purchase | +1,000,000 | $5.00 | $5.0M | 4,448,757 |
| 2023-06-30 | BIOTECH GROWTH N V 10% owner | Purchase | +1,000,000 | $5.00 | $5.0M | 8,117,839 |
| 2023-06-27 | BIOTECH GROWTH N V 10% owner | Purchase | +1,740,000 | $5.49 | $9.6M | 7,117,839 |
| 2023-06-27 | Epstein David M. SEE REMARKS | Sale 10b5-1 | −25,000 | $6.70 | $168K | 671,423 |
| 2023-06-16 | DIXON WENDY L Director | Grant or award | +5,119 | $2.10 | $11K | 27,772 |
| 2023-06-16 | Velleca Mark A. Director | Grant or award | +8,929 | $2.10 | $19K | 41,314 |
| 2023-06-16 | Behbahani Ali Director | Grant or award | +5,655 | $2.10 | $12K | 40,770 |
| 2023-05-16 | Mayweg Alexander Director | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2023-05-16 | Shah Rajeev M. Director | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2023-05-16 | Velleca Mark A. Director | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2023-05-16 | Menzel Garry E Director | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2023-05-16 | Kulkarni Samarth Director | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2023-05-16 | DIXON WENDY L Director | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2023-05-16 | Dhingra Kapil Director | Grant or award · Stock Option (Right to Buy) | +16,500 | 16,500 | ||
| 2023-05-16 | Behbahani Ali Director | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | ||
| 2023-03-16 | DIXON WENDY L Director | Grant or award | +6,437 | $1.67 | $11K | 22,653 |
| 2023-03-16 | Velleca Mark A. Director | Grant or award | +11,228 | $1.67 | $19K | 32,385 |
| 2023-03-16 | Behbahani Ali Director | Grant or award | +7,111 | $1.67 | $12K | 35,115 |
Page 5 of 6 · 114 trades